{"database": "lobbying", "table": "lobbying_activities", "rows": [[2340746, "54c6cef0-6f8b-4a7e-844a-c837c482fe14", "Q3", "MCDERMOTT+ LLC", 401103287, "CAMPAIGN FOR SUSTAINABLE DRUG PRICING", 2019, "third_quarter", "PHA", "Issues relating to prescription drug pricing\nS. 1895 - Lower Health Care Costs Act\nS. 1416 - Affordable Prescriptions for Patients Act\nS. 1224 and H.R. 2374 - Stop Significant and Time-Wasting Abuse Limiting Legitimate Innovation of New Generics (STALLING) Act\nS. 440 - Preserving Access to Cost Effective Drugs Act\nS. 340 and H.R. 965 - CREATES Act\nS. 1391 and H.R. 2296 - Fair Accountability and Innovative Research Drug Pricing Act\nH.R. 1520 - Purple Book Continuity Act\nH.R. 1503 - Orange Book Continuity Act\nS. 659 - Biologic Patent Transparency Act\nS. 551 - Recovering Excessive Funds for Unused and Needless Drugs (REFUND) Act\nS. 1209 - Reforming Evergreening and Manipulation that Extends Drug Years (REMEDY) Act\nH.R. 2113 - Prescription Drug STAR Act\nH.R. 985 - FAST Generics Act of 2019\nH.R. 3 - Lower Drug Costs Now Act of 2019\nS. 2543 - Prescription Drug Pricing Reduction Act of 2019", "Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE", 30000, null, 0, 0, "2019-10-11T14:31:55.327000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2340746"], "units": {}, "query_ms": 40.73668399360031, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}